News|Articles|September 9, 2025

EADV Congress 2025: Late-Breaking Trials Preview

Fact checked by: Tim Smith

A look at 13 phase 2 and phase 3 studies with significant implications from EADV 2025's late-breaking sessions.

Among dermatologists and other clinicians in the skin health space, the European Academy of Dermatology and Venereology (EADV) Congress is more than just a yearly meeting—it is a venue at which new data can shift existing standards of care and redefine treatment approaches. The late-breaking abstract sessions each year during the EADV Congress bring forward findings that can help to not only inform decision-making but also spark debate, collaboration, and momentum across dermatology.